Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
3.
Anat Histol Embryol ; 45(6): 443-449, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26680154

ABSTRACT

External iliac artery atherosclerotic disease and aneurism occur in man. For treatment, imaging is required to facilitate minimally invasive introduction and advancement of stents within the intended vessels. Sheep are commonly used to test and improve stents. However, little information is published regarding the angiographic anatomy of the iliac arteries in the ovine species. The objective of this study was to describe the angiographic anatomy of the iliac arteries in the sheep. Computed tomography (CT) angiography and gross anatomical dissection were performed in, respectively, 10 and 43 adult ewes. Diameters and lengths of the arteries were measured. In comparison with man, salient anatomical differences were identified in the sheep: (1) the absence of common iliac arteries, (2) the common trunk at the origin of internal iliac arteries and (3) the location of the bifurcation of the external iliac arteries into femoral arteries in the pelvis (not in the limb). External iliac arteries in this series of sheep were 86 mm long in average and had a mean diameter of 7.5 mm. Lengths of arteries are only slightly different between man and sheep, while diameters are rather similar. Therefore, the sheep model appears to be sufficiently similar to man to test stent properties. This study provides useful reference images and measures of lengths and diameters of relevant arteries that could be applied to research with ovine models.


Subject(s)
Angiography/methods , Computed Tomography Angiography/veterinary , Femoral Artery/anatomy & histology , Iliac Artery/anatomy & histology , Sheep/anatomy & histology , Angiography/veterinary , Animals , Female , Humans , Models, Animal , Pelvis/blood supply , Sheep, Domestic , Stents
4.
Am J Psychiatry ; 158(1): 140-2, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11136650

ABSTRACT

OBJECTIVE: Converging evidence in patients with obsessive-compulsive disorder (OCD) shows abnormalities of prefrontal areas and basal ganglia, which are also involved in motor control. Event-related desynchronization of mu and beta EEG rhythms is considered a correlate of motor activation during motor preparation and execution, followed by cortical idling or inhibition indicated by event-related synchronization. The authors investigated the circuits involved in motor behavior in OCD by using event-related desynchronization/synchronization. METHOD: Data on alpha and beta event-related desynchronization/synchronization with self-paced movement of the right thumb were obtained by using 29-channel EEG in 10 untreated OCD patients and 10 normal subjects. RESULTS: OCD patients showed delayed onset of mu event-related desynchronization with movement preparation and less postmovement beta synchronization, compared to normal subjects. CONCLUSIONS: Delayed event-related desynchronization in OCD is consistent with involvement of structures related to motor programming, such as basal ganglia. Lower levels of postmovement beta synchronization suggest impairment of the inhibitory system in OCD.


Subject(s)
Basal Ganglia/physiology , Cortical Synchronization/statistics & numerical data , Electroencephalography/statistics & numerical data , Evoked Potentials/physiology , Motor Activity/physiology , Obsessive-Compulsive Disorder/diagnosis , Prefrontal Cortex/physiology , Adult , Beta Rhythm/statistics & numerical data , Electromyography/statistics & numerical data , Female , Functional Laterality/physiology , Humans , Male , Obsessive-Compulsive Disorder/psychology
5.
Neuropsychopharmacology ; 24(1): 31-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11106873

ABSTRACT

In several reports, the acute oral administration of the partial serotonergic agonist meta-chlorophenylpiperazine (mCPP) in dose of 0. 5 mg/kg induced a significant worsening of obsessive-compulsive (OC) symptoms in a number of patients. The aim of our study was to test the 0.25 mg/kg mCPP dose, which was hypothesized to be more specific for OC symptoms and was until now tested only on healthy subjects. In a double-blind, controlled crossover study, 12 OC patients participated on three test days, receiving one of the following on each day: oral 0.5 mg/kg mCPP (standard dose), 0.25 mg/kg mCPP (low dose), or placebo. Behavioral ratings were obtained by means of Visual Analogue Scale (VAS) ratings. The low dose mCPP induced a significant worsening of OC symptoms in 50% (6/12) of the patients, whereas 8.3% (1/12) of the patients showed a worsening after the standard dose. On the other hand, only the standard dose mCPP induced a worsening, although not statistically significant, of anxiety ratings. Our data show that the 0.25 mg/kg dose mCPP induces a specific response in OC symptoms, with little anxiogenic effect. To confirm these preliminary data, future studies will be needed on larger samples and with more sensitive rating scales.


Subject(s)
Obsessive-Compulsive Disorder/drug therapy , Piperazines/administration & dosage , Piperazines/adverse effects , Serotonin Receptor Agonists/administration & dosage , Serotonin Receptor Agonists/adverse effects , Adult , Affect/drug effects , Anxiety/drug therapy , Behavior/drug effects , Behavior/physiology , Cross-Over Studies , Disease Progression , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Serotonin/metabolism , Treatment Outcome
6.
Psychiatry Res ; 77(2): 97-104, 1998 Feb 09.
Article in English | MEDLINE | ID: mdl-9541145

ABSTRACT

A great deal of evidence suggests that a genetic component underlies obsessive-compulsive disorder (OCD). The response to serotonergic medications and the worsening of obsessive symptoms after administration of serotonergic agonists indicate that serotonergic mechanisms are involved in OCD. We investigated the role of the Cys23Ser mutation of the 5HT2C receptor gene in the etiology of this disorder by performing an association study comparing a sample of 109 OCD patients with a sample of 107 healthy control subjects. No allelic or genotypic association of OCD with the 5HT2C receptor gene mutation was revealed in our data. We also extended the association analysis to a subsample of 39 OCD patients that had previously been submitted to a challenge test with clomipramine. In the subsample of OCD patients that received the challenge with clomipramine, no association between the 5HT2C receptor gene mutation and response to the challenge test was found. Our results exclude any specific role of the Cys23Ser mutation of 5HT2C receptor gene in the etiology of OCD: it seems probable that more complex genetic models are needed to explain the involvement of serotonergic elements in the etiology of this disorder.


Subject(s)
Obsessive-Compulsive Disorder/genetics , Polymorphism, Genetic/genetics , RNA, Transfer, Cys/genetics , RNA, Transfer, Ser/genetics , Serotonin/genetics , Adult , Alleles , Clomipramine , Female , Genotype , Humans , Male , Middle Aged , Obsessive-Compulsive Disorder/diagnosis , Point Mutation/genetics , Receptors, Serotonin/genetics , Selective Serotonin Reuptake Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL